BioPharma Retatrutide 5mg

Retatrutide 5mg is an investigational multi-receptor agonist peptide supplied for laboratory and research use only. Each vial contains 5 mg of lyophilized retatrutide.

Retatrutide is a synthetic peptide designed to act on GLP-1, GIP, and glucagon receptors. It is currently under clinical investigation and is not approved by the FDA or other major regulatory agencies for human therapeutic use.

The product is typically provided as a sterile lyophilized powder in a sealed glass vial, intended solely for qualified research applications under controlled laboratory conditions.

Key features (hypothetical packaging/labeling context):

•  Strength: 5 mg per vial or our 10mg version here

•  Form: Lyophilized powder for research reconstitution

•  Appearance: Clear glass vial with color-coded cap and research-only labeling

•  Storage: Store refrigerated or according to research protocol guidelines; protect from light

Important: Retatrutide is an unapproved investigational compound. It is not intended for human consumption, clinical use, or any therapeutic application. Sale and distribution are restricted to legitimate research purposes only. For more information please refer to our comprehensive peptide library.